Gene: IFT46
Official Full Name: intraflagellar transport 46provided by HGNC
Gene Summary: Predicted to be involved in cilium assembly; intraciliary transport; and protein stabilization. Predicted to act upstream of or within smoothened signaling pathway. Located in cytoplasm. Part of intraciliary transport particle B. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17010 | IFT46 Knockout cell line (HeLa) | Human | IFT46 | 1:3~1:6 | Negative | Online Inquiry |
KO17011 | IFT46 Knockout cell line (HCT 116) | Human | IFT46 | 1:2~1:4 | Negative | Online Inquiry |
KO17012 | IFT46 Knockout cell line (HEK293) | Human | IFT46 | 1:3~1:6 | Negative | Online Inquiry |
KO17013 | IFT46 Knockout cell line (A549) | Human | IFT46 | 1:3~1:4 | Negative | Online Inquiry |
IFT46 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the study of the Intraflagellar Transport (IFT) protein IFT46, a critical component involved in the biogenesis and maintenance of cilia and flagella in eukaryotic cells. Through targeted gene editing techniques, specifically CRISPR/Cas9 technology, these cell lines exhibit a complete knockout of the IFT46 gene, thereby allowing researchers to effectively analyze the downstream effects of IFT disruptions on cellular structure and function.
The primary function of IFT46 revolves around its role in the transportation of proteins essential for ciliary assembly and maintenance. By utilizing these knockout cell lines, scientists can investigate various physiological processes impacted by ciliary dysfunction, such as developmental biology, cell signaling, and sensory transduction. The knockout model provides a distinct advantage in delineating the cellular pathways influenced by IFT proteins, thereby revealing novel insights into diseases associated with ciliary defects, including polycystic kidney disease and retinal degeneration.
In research and clinical settings, the IFT46 Gene Knockout Cell Lines offer unprecedented value due to their ability to serve as a powerful platform for high-throughput drug screening, gene therapy investigations, and the study of genetic diseases. Unlike traditional models that may not accurately reflect ciliary function, these knockout lines enable a more targeted approach, ensuring that results are both reliable and reproducible.
Furthermore, the use of IFT46 knockout cell lines can significantly enhance the understanding of ciliary biology, opening new avenues for therapeutic interventions. This product stands out not only due to its specificity in targeting a crucial gene but also because it supports advancements in personalized medicine by offering model systems that closely mimic human disease states.
Our company has a strong commitment to providing high-quality biological products that empower the scientific community. With a robust background in gene editing technologies and cell line development, we ensure that our products meet the highest standards of precision and reliability, making them indispensable tools for researchers and clinicians alike.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.